Greenwich LifeSciences, Inc.
GLSI · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Jun 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$19.4M | −$17.6M | −10.3% |
| Net income | −$19.4M | −$17.4M | −11.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 16, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$5.90M | −$3.70M | −59.5% |
| Net income | −$5.80M | −$3.70M | −56.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Greenwich LifeSciences's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Jun 2026.
- Was Greenwich LifeSciences profitable in FY2025?
- No: net income was −$19.4M and operating income −$19.4M in FY2025.
- What was Greenwich LifeSciences's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 16, 2026.